AQILION AB
556623-2095ActiveDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Biotechnology Company / Public Limited Companyaqilion.com
Oversigt
- 5–9
- Medarbejdere
- 2.5–5mio SEK
- Omsætning
- 2002
- Grundlagt
Beskrivelse
Aqilion is a Swedish biotech company dedicated to developing innovative new treatments for diseases stemming from chronic inflammation and dysfunctional immunological reactions, such as autoimmune disorders. Their core mission involves identifying promising scientific ideas based on solid biological...
Tags
B2BPharmaceuticalsTechnology
Nøgleord
Autoimmunity